GetTopicDetailResponse(id=980015892a7, topicName=SAR442168, introduction=SAR442168, content=null, image=null, comments=2, allHits=1008, url=https://h5.medsci.cn/topic?id=15892, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99504, tagList=[TagDto(tagId=99504, tagName=SAR442168)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1968017, encodeId=8e9a196801e8c, content=<a href='/topic/show?id=980015892a7' target=_blank style='color:#2F92EE;'>#SAR442168#</a>, objectTitle=實(shí)驗(yàn)性BTK抑制劑SAR442168可顯著降低多發(fā)性硬化癥的疾病活動, objectType=article, longId=192862, objectId=cb3a1928621f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb3a1928621f, replyNumber=0, likeNumber=82, createdTime=2020-06-09, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb3a1928621f, moduleTitle=實(shí)驗(yàn)性BTK抑制劑SAR442168可顯著降低多發(fā)性硬化癥的疾病活動, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cb3a1928621f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1968016, encodeId=d9661968016ac, content=<a href='/topic/show?id=980015892a7' target=_blank style='color:#2F92EE;'>#SAR442168#</a>, objectTitle=復(fù)發(fā)性多發(fā)性硬化癥（MS）的治療再迎進(jìn)展：BTK抑制劑SAR442168達(dá)到中期研究的主要終點(diǎn), objectType=article, longId=187657, objectId=c23618e6572f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c23618e6572f, replyNumber=0, likeNumber=105, createdTime=2020-09-03, rootId=0, userName=luoxiaog, userId=02f5179, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c23618e6572f, moduleTitle=復(fù)發(fā)性多發(fā)性硬化癥（MS）的治療再迎進(jìn)展：BTK抑制劑SAR442168達(dá)到中期研究的主要終點(diǎn), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c23618e6572f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
